Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2010

01-09-2010 | Original Article

Prevalence of Vitamin D Deficiency in Chronic Liver Disease

Authors: J. Arteh, S. Narra, S. Nair

Published in: Digestive Diseases and Sciences | Issue 9/2010

Login to get access

Abstract

Vitamin D deficiency has been associated with cholestatic liver disease such as primary biliary cirrhosis. Some studies have suggested that cirrhosis can predispose patients to development of osteoporosis because of altered calcium and vitamin D homeostasis. The aim of this study was to determine the prevalence of vitamin D deficiency in patients with chronic liver disease.

Methods

One hundred and eighteen consecutive patients (43 with hepatitis C cirrhosis, 57 with hepatitis C but no cirrhosis, 18 with nonhepatitis C-related cirrhosis) attending the University of Tennessee Hepatology Clinic had their 25-hydroxyvitamin D level measured. Severity of vitamin D deficiency was graded as mild (20–32 ng/ml), moderate (7–19 ng/ml) or severe (<7 ng/ml), normal being >32 ng/ml.

Results

Of patients, 109/118 (92.4%) had some degree of vitamin D deficiency. In the hepatitis C cirrhosis group, 16.3% (7/43) had mild, 48.8% (21/43) had moderate, and 30.2% (13/43) had severe vitamin D deficiency. In the hepatitis C noncirrhotic group, 22.8% (19/57) had mild, 52.6% (30/57) had moderate, and 14% (8/57) had severe vitamin D deficiency. In the nonhepatitis C-related cirrhosis group, 38.9% (7/18) had mild, 27.8% (5/18) had moderate, and 27.8% (5/18) had severe vitamin D deficiency. Severe vitamin D deficiency (<7 ng/ml) was more common among patients with cirrhosis compared with noncirrhotics (29.5% versus 14.1%, P value = 0.05). Female gender, African American race, and cirrhosis were independent predictors of severe vitamin D deficiency in chronic liver disease.

Conclusion

Vitamin D deficiency is universal (92%) among patients with chronic liver disease, and at least one-third of them suffer from severe vitamin D deficiency. African American females are at highest risk of vitamin D deficiency.
Literature
1.
go back to reference DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl):1689S–1696S.PubMed DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl):1689S–1696S.PubMed
2.
go back to reference Imawari M, Akanuma Y, Itakura H, Muto Y, Kosaka K, Goodman DS. The effects of diseases of the liver on serum 25 hydroxyvitamin D and on serum binding protein for vitamin D and its metabolites. J Lab Clin Med. 1979;93:171–180.PubMed Imawari M, Akanuma Y, Itakura H, Muto Y, Kosaka K, Goodman DS. The effects of diseases of the liver on serum 25 hydroxyvitamin D and on serum binding protein for vitamin D and its metabolites. J Lab Clin Med. 1979;93:171–180.PubMed
4.
go back to reference Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res. 2008;23:143–150.CrossRefPubMed Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res. 2008;23:143–150.CrossRefPubMed
5.
go back to reference Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005;35:290–304.CrossRefPubMed Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005;35:290–304.CrossRefPubMed
6.
go back to reference Tsuneoka K, Tameda Y, Takase K, et al. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 1996;31:669–678.CrossRefPubMed Tsuneoka K, Tameda Y, Takase K, et al. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 1996;31:669–678.CrossRefPubMed
7.
go back to reference Masuda S, Okano T, Osawa K, et al. Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo). 1989;35:225–234. Masuda S, Okano T, Osawa K, et al. Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo). 1989;35:225–234.
8.
go back to reference Bouillon R, Auwerx J, Dekeyser L, et al. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab. 1984;59:86–89.CrossRefPubMed Bouillon R, Auwerx J, Dekeyser L, et al. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab. 1984;59:86–89.CrossRefPubMed
9.
go back to reference Chen CC, Wang SS, Jeng FS, et al. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol. 1996;11:417–421.CrossRefPubMed Chen CC, Wang SS, Jeng FS, et al. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol. 1996;11:417–421.CrossRefPubMed
10.
go back to reference Hepner GW, Roginsky M, Moo HF. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976;21:527–532.CrossRefPubMed Hepner GW, Roginsky M, Moo HF. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976;21:527–532.CrossRefPubMed
11.
go back to reference Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol. 2001;16:1022–1027.CrossRefPubMed Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol. 2001;16:1022–1027.CrossRefPubMed
12.
go back to reference Monegal A, Navasa M, Guanabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148–154.CrossRefPubMed Monegal A, Navasa M, Guanabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148–154.CrossRefPubMed
13.
go back to reference Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–687.CrossRefPubMed Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–687.CrossRefPubMed
14.
go back to reference Koli K, Keski-Oja J. 1alpha, 25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000;11:221–229.PubMed Koli K, Keski-Oja J. 1alpha, 25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000;11:221–229.PubMed
15.
go back to reference Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787–796.CrossRefPubMed Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787–796.CrossRefPubMed
16.
go back to reference Dobak J, Grzybowski J, Liu FT, et al. 1, 25-dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci. 1994;8:18–24.CrossRefPubMed Dobak J, Grzybowski J, Liu FT, et al. 1, 25-dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci. 1994;8:18–24.CrossRefPubMed
17.
go back to reference Garcíade León Mdel C, Montfort I, Tello Montes E, et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp Mol Pathol. 2006;80(1):97–108. Epub 2005 Dec 5.PubMed Garcíade León Mdel C, Montfort I, Tello Montes E, et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp Mol Pathol. 2006;80(1):97–108. Epub 2005 Dec 5.PubMed
18.
go back to reference Hamada T, Fondevila C, Busuttil RW, Coito AJ. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology. 2008;47(1):186–198.CrossRefPubMed Hamada T, Fondevila C, Busuttil RW, Coito AJ. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology. 2008;47(1):186–198.CrossRefPubMed
19.
go back to reference Khandoga A, Kessler JS, Hanschen M, et al. Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J Leukoc Biol. 2006;79:1295–1305.CrossRefPubMed Khandoga A, Kessler JS, Hanschen M, et al. Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J Leukoc Biol. 2006;79:1295–1305.CrossRefPubMed
20.
go back to reference Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol. 2007;5(4):513–520. Epub 2007 Jan 10.CrossRefPubMed Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol. 2007;5(4):513–520. Epub 2007 Jan 10.CrossRefPubMed
21.
go back to reference Mawer EB, Klass HJ, Warnes TW, et al. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond). 1985;69:561–570. Mawer EB, Klass HJ, Warnes TW, et al. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond). 1985;69:561–570.
22.
go back to reference Caniggia A, Lore F, di Cairano G, et al. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27:815–824.CrossRefPubMed Caniggia A, Lore F, di Cairano G, et al. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27:815–824.CrossRefPubMed
23.
go back to reference Skinner RK, Sherlock S, Long RG, et al. 25-hydroxylation of vitamin D in primary biliary cirrhosis. Lancet. 1977;1:720–721.CrossRefPubMed Skinner RK, Sherlock S, Long RG, et al. 25-hydroxylation of vitamin D in primary biliary cirrhosis. Lancet. 1977;1:720–721.CrossRefPubMed
24.
go back to reference Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073–1090.CrossRefPubMed Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073–1090.CrossRefPubMed
Metadata
Title
Prevalence of Vitamin D Deficiency in Chronic Liver Disease
Authors
J. Arteh
S. Narra
S. Nair
Publication date
01-09-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1069-9

Other articles of this Issue 9/2010

Digestive Diseases and Sciences 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.